Department of Diabetes and Metabolic Medicine, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
J Diabetes Complications. 2010 Sep-Oct;24(5):345-53. doi: 10.1016/j.jdiacomp.2010.06.004. Epub 2010 Jul 24.
Several meta-analyses have shown that diabetes mellitus affects the risk of certain site-specific cancers. However, a meta-analysis on the overall risk of cancer has not yet been performed.
We performed a search of MEDLINE and the Cochrane Library for pertinent articles (including their references) that had been published as of June 10, 2010. English-language, original observational cohort studies and case-control studies conducted in Japan were included for a qualitative review and a meta-analysis.
A total of 22,485 cancer cases were reported in four cohort studies and one case-control study (with a total of 250,479 subjects). With these five reports, a meta-analysis of the all-cancer risk in both men and women showed an increased risk in subjects with diabetes, compared with nondiabetic subjects (OR 1.70, 95% CI 1.38-2.10). The increase in the risk ratio adjusted for possible confounders was significant in men and borderline in women (adjusted RR 1.25, 95% CI 1.06-1.46 in men; adjusted RR 1.23, 95% CI 0.97-1.56 in women). An analysis of site-specific cancers revealed increased risks for incident hepatocellular cancer (OR 3.64, 95% CI 2.61-5.07) and endometrial cancer (OR 3.43, 95% CI 1.53-7.72).
As is the case in Western countries, Asian people with diabetes have a higher risk of incident cancer than those without diabetes. Cancer prevention and early detection should be important components of diabetes management in light of the exponentially increasing prevalence of diabetes, which has substantial implications in public health and clinical practices.
几项荟萃分析表明,糖尿病会影响某些特定部位癌症的风险。然而,目前尚未对癌症的总体风险进行荟萃分析。
我们对 MEDLINE 和 Cochrane 图书馆中截至 2010 年 6 月 10 日发表的相关文章(包括其参考文献)进行了检索。纳入了日本进行的英语原始观察性队列研究和病例对照研究,进行了定性综述和荟萃分析。
四项队列研究和一项病例对照研究共报告了 22485 例癌症病例(共 250479 例受试者)。通过这五项报告,对男性和女性的所有癌症风险进行荟萃分析显示,与非糖尿病患者相比,糖尿病患者的风险增加(OR 1.70,95%CI 1.38-2.10)。在调整了可能的混杂因素后,风险比的增加在男性中显著,在女性中则处于边缘(男性调整 RR 1.25,95%CI 1.06-1.46;女性调整 RR 1.23,95%CI 0.97-1.56)。对特定部位癌症的分析显示,肝癌(OR 3.64,95%CI 2.61-5.07)和子宫内膜癌(OR 3.43,95%CI 1.53-7.72)的发病风险增加。
与西方国家一样,亚洲糖尿病患者的癌症发病风险高于非糖尿病患者。鉴于糖尿病的患病率呈指数级增长,对公共卫生和临床实践具有重大影响,癌症预防和早期发现应成为糖尿病管理的重要组成部分。